In Law360, Health Care Attorneys Examine CMS Proposed Rule for Value-Based Purchasing Arrangements
The Centers for Medicare & Medicaid Services issued a proposed rule that, if finalized, would modify significantly the current Medicaid Drug Rebate Program regulations. The proposed rule puts forth new regulatory policies, as well as provides clarification with regard to already established policies, intended to encourage drug manufacturers and states to participate in value-based purchasing arrangements.
In a Law360 article, health care partner Tom Bulleit summarizes key elements of the proposed rule and its implications.